Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Richard Miller

Concepts (175)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Inhibitor of Apoptosis Proteins
4
2017
37
1.180
Why?
Radiation Tolerance
4
2017
172
0.890
Why?
Repressor Proteins
3
2016
373
0.780
Why?
Emodin
2
2017
8
0.750
Why?
Metformin
2
2017
92
0.710
Why?
Radiation-Protective Agents
2
2014
101
0.680
Why?
Oxidants
1
2016
89
0.680
Why?
Fibrosarcoma
1
2016
90
0.670
Why?
Sex Chromosome Aberrations
1
2015
28
0.640
Why?
Aneuploidy
1
2015
58
0.630
Why?
Acute Radiation Syndrome
1
2014
2
0.610
Why?
Radiation Injuries, Experimental
1
2014
48
0.590
Why?
Sulfhydryl Compounds
1
2014
76
0.570
Why?
Pregnancy Complications
2
2012
322
0.510
Why?
Pregnancy Complications, Infectious
1
2012
118
0.490
Why?
Tumor Suppressor Protein p53
4
2017
352
0.470
Why?
Gene Expression Regulation, Neoplastic
1
2016
1151
0.460
Why?
Ultrasonography, Prenatal
5
2009
164
0.450
Why?
Influenza, Human
1
2012
353
0.410
Why?
Acetylcysteine
4
2017
74
0.400
Why?
Mice, Inbred C3H
4
2017
388
0.390
Why?
Cell Line, Tumor
8
2018
2316
0.350
Why?
Asthma
1
2012
779
0.320
Why?
Reactive Oxygen Species
3
2017
436
0.320
Why?
Pregnancy
10
2015
2535
0.310
Why?
Trisomy
3
2009
63
0.300
Why?
Bezoars
1
2003
5
0.300
Why?
Adaptation, Physiological
4
2015
305
0.290
Why?
Pica
1
2003
14
0.290
Why?
Dose-Response Relationship, Radiation
4
2017
202
0.290
Why?
Hirschsprung Disease
1
2003
37
0.290
Why?
Abnormalities, Multiple
4
2009
239
0.280
Why?
Ileum
1
2003
182
0.270
Why?
Oxygen
2
2018
668
0.260
Why?
Diarrhea
1
2003
201
0.260
Why?
Antioxidants
2
2016
224
0.250
Why?
Sarcoma
2
2014
221
0.250
Why?
Superoxide Dismutase
2
2012
183
0.230
Why?
Radiotherapy, Image-Guided
2
2018
52
0.230
Why?
Cell Survival
4
2016
998
0.230
Why?
Pregnancy Trimester, Second
3
2009
67
0.220
Why?
Colectomy
2
2016
204
0.220
Why?
Mice
8
2018
10516
0.210
Why?
Congenital Abnormalities
2
2009
65
0.200
Why?
Gamma Rays
1
2016
85
0.170
Why?
Hindlimb
1
2016
86
0.170
Why?
Neoplasm Transplantation
1
2016
395
0.160
Why?
Colonic Diseases
1
2016
103
0.160
Why?
Pregnancy Outcome
3
2012
250
0.160
Why?
Neoplasms, Experimental
1
2017
282
0.160
Why?
Turner Syndrome
1
2015
30
0.160
Why?
Antigens, Neoplasm
1
2017
292
0.160
Why?
False Positive Reactions
1
2015
235
0.150
Why?
Female
14
2017
41680
0.150
Why?
Mesna
1
2014
10
0.150
Why?
Health Care Reform
1
2016
124
0.150
Why?
Protein Transport
1
2016
423
0.150
Why?
Colony-Forming Units Assay
1
2014
43
0.150
Why?
Captopril
1
2014
25
0.150
Why?
Emergency Medical Services
1
2016
182
0.150
Why?
Mercaptoethylamines
2
2012
55
0.150
Why?
Amifostine
1
2014
51
0.150
Why?
Drug Evaluation, Preclinical
1
2014
113
0.150
Why?
RNA, Small Interfering
1
2016
565
0.150
Why?
Free Radical Scavengers
1
2014
62
0.150
Why?
Cell Line, Transformed
1
2014
230
0.140
Why?
Animals
8
2018
25685
0.140
Why?
Drug Synergism
1
2014
320
0.140
Why?
Postoperative Complications
1
2003
2134
0.140
Why?
Mice, Inbred C57BL
3
2014
3051
0.130
Why?
Anti-Asthmatic Agents
1
2012
60
0.130
Why?
Risk Reduction Behavior
1
2012
99
0.130
Why?
Humans
17
2017
75744
0.130
Why?
Obstetrics
1
2012
84
0.120
Why?
Endothelial Cells
1
2014
430
0.120
Why?
Ambulatory Care
1
2012
165
0.120
Why?
Micronuclei, Chromosome-Defective
1
2010
5
0.120
Why?
NF-kappa B
1
2015
483
0.120
Why?
Fibroblasts
1
2014
710
0.120
Why?
Influenza Vaccines
1
2012
174
0.120
Why?
Smoking Cessation
1
2012
161
0.120
Why?
Cell Proliferation
1
2017
1524
0.120
Why?
Polyploidy
1
2009
17
0.110
Why?
alpha-Tocopherol
1
2009
10
0.110
Why?
Keratosis, Actinic
1
2009
13
0.110
Why?
Oligohydramnios
1
2008
3
0.100
Why?
Sex Chromosomes
1
2009
49
0.100
Why?
Ultrasonography, Doppler
1
2009
66
0.100
Why?
Chromosomes, Human, Pair 9
1
2009
91
0.100
Why?
Colonic Neoplasms
1
2013
535
0.100
Why?
Chromosomes, Human, Pair 18
1
2008
47
0.100
Why?
Down Syndrome
1
2008
56
0.100
Why?
Antiviral Agents
1
2012
458
0.100
Why?
Fetal Diseases
1
2008
87
0.100
Why?
Gene Expression Regulation
1
2017
1835
0.100
Why?
Cells, Cultured
1
2014
2878
0.100
Why?
Chromosomes, Human, Pair 13
1
2007
52
0.090
Why?
Pregnancy Trimester, First
1
2007
58
0.090
Why?
Spine
1
2008
107
0.090
Why?
Blood Transfusion, Intrauterine
1
2006
5
0.090
Why?
Blood Group Antigens
1
2006
14
0.090
Why?
Pregnancy Complications, Hematologic
1
2006
16
0.090
Why?
Retrospective Studies
7
2016
6534
0.080
Why?
Electron Spin Resonance Spectroscopy
2
2018
288
0.080
Why?
Isoantibodies
1
2006
109
0.080
Why?
Radiation Dosage
2
2017
224
0.070
Why?
Colostomy
1
2003
22
0.070
Why?
Hyponatremia
1
2003
24
0.070
Why?
Dehydration
1
2003
23
0.070
Why?
Ileostomy
1
2003
44
0.070
Why?
Acidosis
1
2003
63
0.070
Why?
Colorectal Neoplasms
1
2010
794
0.070
Why?
Anastomosis, Surgical
1
2003
282
0.060
Why?
Adult
3
2016
24267
0.060
Why?
Fetal Growth Retardation
2
2008
62
0.050
Why?
HCT116 Cells
1
2017
139
0.050
Why?
Half-Life
1
2017
108
0.050
Why?
Massachusetts
1
2016
70
0.040
Why?
Radiation-Sensitizing Agents
1
2017
106
0.040
Why?
Apoptosis
2
2015
1800
0.040
Why?
Child, Preschool
1
2003
3586
0.040
Why?
Kaplan-Meier Estimate
1
2018
866
0.040
Why?
Insurance, Health
1
2016
169
0.040
Why?
Male
5
2016
39292
0.040
Why?
Health Care Costs
1
2016
246
0.040
Why?
Socioeconomic Factors
1
2016
574
0.040
Why?
Ethylnitrosourea
1
2012
28
0.030
Why?
Alkylating Agents
1
2012
33
0.030
Why?
Genomic Instability
1
2012
66
0.030
Why?
Genomics
1
2017
545
0.030
Why?
Dose-Response Relationship, Drug
1
2017
2063
0.030
Why?
Cohort Studies
2
2009
2450
0.030
Why?
Xenograft Model Antitumor Assays
1
2013
427
0.030
Why?
Hospitalization
1
2016
705
0.030
Why?
Superoxides
1
2010
78
0.030
Why?
Biogenic Polyamines
1
2009
3
0.030
Why?
Chromosomes, Human, Y
1
2009
16
0.030
Why?
Proliferating Cell Nuclear Antigen
1
2009
61
0.030
Why?
Administration, Topical
1
2009
97
0.030
Why?
Nuchal Translucency Measurement
1
2008
3
0.030
Why?
Karyotyping
1
2009
263
0.030
Why?
Chromosomes, Human, X
1
2009
55
0.030
Why?
Chemoprevention
1
2009
87
0.030
Why?
Mosaicism
1
2008
68
0.030
Why?
Biometry
1
2008
66
0.020
Why?
Mice, Knockout
1
2013
1838
0.020
Why?
Scoliosis
1
2008
70
0.020
Why?
Chromatography, High Pressure Liquid
1
2009
313
0.020
Why?
Syndrome
1
2008
424
0.020
Why?
Gestational Age
1
2008
297
0.020
Why?
Cesarean Section
1
2008
116
0.020
Why?
Chromosome Aberrations
1
2009
392
0.020
Why?
Abortion, Induced
1
2008
77
0.020
Why?
Maine
1
2006
1
0.020
Why?
Rh Isoimmunization
1
2006
8
0.020
Why?
Blood Grouping and Crossmatching
1
2006
14
0.020
Why?
Mutation
1
2017
3584
0.020
Why?
Antibody Formation
1
2006
194
0.020
Why?
Databases, Factual
1
2008
754
0.020
Why?
Immunohistochemistry
1
2009
1776
0.020
Why?
Incidence
1
2009
1599
0.020
Why?
Mass Screening
1
2008
577
0.020
Why?
Imaging, Three-Dimensional
1
2008
552
0.020
Why?
Diagnosis, Differential
1
2008
1562
0.020
Why?
Sensitivity and Specificity
1
2009
2053
0.020
Why?
Predictive Value of Tests
1
2008
1587
0.020
Why?
Neoplasms
1
2017
2374
0.020
Why?
Reproducibility of Results
1
2009
2515
0.020
Why?
Prevalence
1
2006
1126
0.020
Why?
Risk Assessment
1
2009
2096
0.010
Why?
Signal Transduction
1
2012
3268
0.010
Why?
Risk Factors
1
2008
5034
0.010
Why?
Middle Aged
1
2016
24119
0.010
Why?
Young Adult
1
2009
5323
0.010
Why?
Aged
1
2009
17293
0.010
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_